Literature DB >> 21886466

Enterocutaneous fistula: medical and surgical management including patients with Crohn's disease.

Guy R Orangio1.   

Abstract

Patients with inflammatory bowel disease (IBD) and especially Crohn's disease can be challenging for even the most seasoned of surgeons. Development of an enterocutaneous fistula (ECF) in these patients further adds a level of complexity that requires a well-planned and defined management strategy. The role of the surgeon in caring for these patients should be as the leader of a multidisciplinary team, directing the care of the other specialists, all while determining if, and when, the patient requires operative intervention. Although medical management has come a long way in these and similar patients, surgery is still needed in a vast majority of patients. Therefore, understanding the evaluation, initial management, and important technical considerations for care of IBD and other complex patients with ECFs is a difficult, yet much needed, task for which the surgeon should be prepared.

Entities:  

Keywords:  Crohn's disease; Enterocutaneous fistula; inflammatory bowel disease

Year:  2010        PMID: 21886466      PMCID: PMC2967316          DOI: 10.1055/s-0030-1262984

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  17 in total

1.  Impact of complex Crohn's disease on the outcome of laparoscopic ileocecal resection: a comparative clinical study in 124 patients.

Authors:  Perrine Goyer; Arnaud Alves; Frédéric Bretagnol; Yoram Bouhnik; Patrice Valleur; Yves Panis
Journal:  Dis Colon Rectum       Date:  2009-02       Impact factor: 4.585

Review 2.  Classification and pathophysiology of enterocutaneous fistulas.

Authors:  S M Berry; J E Fischer
Journal:  Surg Clin North Am       Date:  1996-10       Impact factor: 2.741

3.  Management of abdominal wound dehiscence using vacuum assisted closure in patients with compromised healing.

Authors:  Lior Heller; Scott L Levin; Charles E Butler
Journal:  Am J Surg       Date:  2006-02       Impact factor: 2.565

4.  Alanyl-glutamine-supplemented parenteral nutrition increases luminal mucus gel and decreases permeability in the rat small intestine.

Authors:  J Khan; Y Iiboshi; L Cui; M Wasa; K Sando; Y Takagi; A Okada
Journal:  JPEN J Parenter Enteral Nutr       Date:  1999 Jan-Feb       Impact factor: 4.016

5.  Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis.

Authors:  Chelliah R Selvasekar; Robert R Cima; David W Larson; Eric J Dozois; Jeffrey R Harrington; William S Harmsen; Edward V Loftus; William J Sandborn; Bruce G Wolff; John H Pemberton
Journal:  J Am Coll Surg       Date:  2007-05       Impact factor: 6.113

6.  Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.

Authors:  Kweku A Appau; Victor W Fazio; Bo Shen; James M Church; Bret Lashner; Feza Remzi; Aaron Brzezinski; Scott A Strong; Jeffrey Hammel; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

7.  Remicade does not abolish the need for surgery in fistulizing Crohn's disease.

Authors:  Lisa S Poritz; William A Rowe; Walter A Koltun
Journal:  Dis Colon Rectum       Date:  2002-06       Impact factor: 4.585

8.  Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes.

Authors:  Jose L Martinez; Enrique Luque-de-Leon; Juan Mier; Roberto Blanco-Benavides; Felipe Robledo
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

Review 9.  Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Authors:  B W Behm; S J Bickston
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

10.  Treatment strategies in 135 consecutive patients with enterocutaneous fistulas.

Authors:  Ruben G J Visschers; Steven W M Olde Damink; Bjorn Winkens; Peter B Soeters; Wim G van Gemert
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

View more
  5 in total

1.  Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; S Faenza; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

2.  Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis.

Authors:  David A Schwartz; Ignacio Tagarro; Mary Carmen Díez; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2019-10-18       Impact factor: 5.325

3.  Enterocutaneous Fistula: Open Repair after Unsuccessful Stenting-A Case Report.

Authors:  Valerija Mosenko; Saulius Jurevičius; Audrius Šileikis
Journal:  Medicina (Kaunas)       Date:  2022-02-02       Impact factor: 2.430

Review 4.  Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Authors:  Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 5.  Enterocutaneous fistulas: a primer for radiologists with emphasis on CT and MRI.

Authors:  Massimo Tonolini; Paolo Magistrelli
Journal:  Insights Imaging       Date:  2017-09-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.